AIDS Clinical Trials Group

REPRIEVE: 7500 Participants Enrolled!

Congratulations to the
University of Southern
California CRS, Site 1201 for
enrolling the 7500th participant!
Our Mission

The mission of the ACTG Network
is to cure HIV and reduce the
burden of disease due to HIV
and its complications, including
tuberculosis and viral hepatitis.
PHOENIx is rising!

The A5300B/I2003B/PHOENIx (PHOENIx MDR-TB)
protocol development is moving forward rapidly
About the Clinical Trials Process

Learn more about ACTG Network clinical trials
Open and Enrolling Studies

A5351s: Immune-modularity drugs and CMV replication

More Studies >
Featured ACTG Publications

Effect of HIV-1 infection on human DNA yield from saliva.

prev Stop next

View All Slides

For Researchers

Who are the ACTG Collaborators?

Submit a Proposal

Specimen Repository Website

Access to Published Data

For Potential Study Participants

Trials Open to Enrollment

About the Clinical Trials Process

Recent Study Results

Clinical Trials Resources

ACTG News & Meeting Information

Social Media

Featured Content

Newsletter Article

Guest Blog: Outreach, Recruitment and Retention Working Group Tips

Go to ACTG Newsletters »

Clinical Trial Update

A5366: Effects of SERM and HDACi on HIV-1

Go to all Trials Open to Enrollment »

Educational Video

Understanding the Importance of Women and Minorities Participating in ACTG Network Clinical Trials

Go to all ACTG Videos »